Literature DB >> 19449889

Max-E47, a designed minimalist protein that targets the E-box DNA site in vivo and in vitro.

Jing Xu1, Gang Chen, Antonia T De Jong, S Hesam Shahravan, Jumi A Shin.   

Abstract

Max-E47 is a designed hybrid protein comprising the Max DNA-binding basic region and E47 HLH dimerization subdomain. In the yeast one-hybrid system (Y1H), Max-E47 shows strong transcriptional activation from the E-box site, 5'-CACGTG, targeted by the Myc/Max/Mad network of transcription factors; two mutants, Max-E47Y and Max-E47YF, activate more weakly from the E-box in the Y1H. Quantitative fluorescence anisotropy titrations to gain free energies of protein:DNA binding gave low nanomolar K(d) values for the native MaxbHLHZ, Max-E47, and the Y and YF mutants binding to the E-box site (14, 15, 9, and 6 nM, respectively), with no detectable binding to a nonspecific control duplex. Because these minimalist, E-box-binding hybrids have no activation domain and no interactions with the c-MycbHLHZ, as shown by the yeast two-hybrid assay, they can potentially serve as dominant-negative inhibitors that suppress activation of E-box-responsive genes targeted by transcription factors including the c-Myc/Max complex. As proof-of-principle, we used our modified Y1H, which allows direct competition between two proteins vying for a DNA target, to show that Max-E47 effectively outcompetes the native MaxbHLHZ for the E-box; weaker competition is observed from the two mutants, consistent with Y1H results. These hybrids provide a minimalist scaffold for further exploration of the relationship between protein structure and DNA-binding function and may have applications as protein therapeutics or biochemical probes capable of targeting the E-box site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449889      PMCID: PMC2734406          DOI: 10.1021/ja901306q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  60 in total

Review 1.  Artificial zinc finger peptides: creation, DNA recognition, and gene regulation.

Authors:  M Nagaoka; Y Sugiura
Journal:  J Inorg Biochem       Date:  2000-11       Impact factor: 4.155

2.  The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity.

Authors:  Jun Lu; Steven R Sloan
Journal:  Biochem Biophys Res Commun       Date:  2002-02-08       Impact factor: 3.575

3.  Development of zinc finger domains for recognition of the 5'-ANN-3' family of DNA sequences and their use in the construction of artificial transcription factors.

Authors:  B Dreier; R R Beerli; D J Segal; J D Flippin; C F Barbas
Journal:  J Biol Chem       Date:  2001-05-04       Impact factor: 5.157

4.  Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex.

Authors:  Naud Jean-François; Gagnon Frédéric; Wellinger Raymund; Chabot Benoit; Pierre Lavigne
Journal:  J Mol Biol       Date:  2003-03-07       Impact factor: 5.469

5.  X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.

Authors:  Satish K Nair; Stephen K Burley
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

6.  Max-independent functions of Myc in Drosophila melanogaster.

Authors:  Dominik Steiger; Michael Furrer; Daniela Schwinkendorf; Peter Gallant
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

7.  Short, hydrophobic, alanine-based proteins based on the basic region/leucine zipper protein motif: overcoming inclusion body formation and protein aggregation during overexpression, purification, and renaturation.

Authors:  A R Lajmi; T R Wallace; J A Shin
Journal:  Protein Expr Purif       Date:  2000-04       Impact factor: 1.650

8.  High efficiency transformation of Schizosaccharomyces pombe pretreated with thiol compounds by electroporation.

Authors:  M Suga; T Hatakeyama
Journal:  Yeast       Date:  2001-08       Impact factor: 3.239

9.  The basic helix-loop-helix domain of the aryl hydrocarbon receptor nuclear transporter (ARNT) can oligomerize and bind E-box DNA specifically.

Authors:  J L Huffman; A Mokashi; H P Bächinger; R G Brennan
Journal:  J Biol Chem       Date:  2001-08-13       Impact factor: 5.157

10.  Sequence-specific recognition of DNA by hydrophobic, alanine-rich mutants of the basic region/leucine zipper motif investigated by fluorescence anisotropy.

Authors:  Gregory H Bird; Ajay R Lajmi; Jumi A Shin
Journal:  Biopolymers       Date:  2002-10-05       Impact factor: 2.505

View more
  5 in total

1.  Reengineering natural design by rational design and in vivo library selection: the HLH subdomain in bHLHZ proteins is a unique requirement for DNA-binding function.

Authors:  Jing Xu; Antonia T De Jong; Gang Chen; Hiu-Kwan Chow; Christopher O Damaso; Adrian Schwartz Mittelman; Jumi A Shin
Journal:  Protein Eng Des Sel       Date:  2010-01-19       Impact factor: 1.650

Review 2.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

3.  Crystal structure of the minimalist Max-E47 protein chimera.

Authors:  Faraz Ahmadpour; Rodolfo Ghirlando; Antonia T De Jong; Melanie Gloyd; Jumi A Shin; Alba Guarné
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

4.  Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.

Authors:  Mark J Demma; Claudio Mapelli; Angie Sun; Smaranda Bodea; Benjamin Ruprecht; Sarah Javaid; Derek Wiswell; Eric Muise; Shiying Chen; John Zelina; Federica Orvieto; Alessia Santoprete; Simona Altezza; Federica Tucci; Enrique Escandon; Brian Hall; Kallol Ray; Abbas Walji; Jennifer O'Neil
Journal:  Mol Cell Biol       Date:  2019-10-28       Impact factor: 4.272

Review 5.  Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.

Authors:  Sarah K Madden; Aline Dantas de Araujo; Mara Gerhardt; David P Fairlie; Jody M Mason
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.